Look for:

GENSIGHT BIOLOGICS SA


ISIN:
FR0013183985
WKN:
-
2024/10/18 19:33:02
Price
0.3465 EUR
Difference -10.00% (-0.04)

General attributes

ISINFR0013183985
SymbolSIGHT
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)37 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.384 EUR
High0.398 EUR
Low0.3465 EUR
Close (prev. day)0.385 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades16
Last size0

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/10/18 19:33:02
Price
0.3465 EUR
Difference -10.00% (-0.04)

General attributes

ISINFR0013183985
SymbolSIGHT
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)37 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.384 EUR
High0.398 EUR
Low0.3465 EUR
Close (prev. day)0.385 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades16
Last size0

Performance and Risk

6m1y3y
Perf (%)-15.18%-50.00%-95.17%
Perf (abs.)-0.06-0.35-6.82
Beta1.121.051.00
Volatility68.0180.18116.60
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.3905 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)0.3762 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)0.3502 EUR (1)
Ø price 250 days | Ø volume 250 days (pcs.)0.4034 EUR (0)
YTD High | date0.5760 EUR (2024/03/06)
YTD Low | date0.2800 EUR (2024/08/08)
52 Weeks High | date0.6960 EUR (2023/10/19)
52 Weeks Low | date0.2800 EUR (2024/08/08)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/10/1819:330.3465 EUR0.0016
Duesseldorf2024/10/1808:110.3785 EUR0.003
Euronext Paris2024/10/1817:350.3465 EUR0.30440
FINRA other OTC Issues2024/07/2218:570.32 USD0.001
Frankfurt2024/10/1808:030.344 EUR0.002
London Stock Exchange2023/05/1213:460.956 EUR0.011
Munich2024/10/1808:050.3955 EUR0.002
Stuttgart2024/10/1815:470.3725 EUR0.0010
Tradegate2024/10/1822:260.3465 EUR0.014

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=152813&ID_TYPE_IMAGE_LOGO=2

Contact Details

GENSIGHT BIOLOGICS SA
- -
rue du Faubourg Saint-Antoine 74 75012 Paris
Telefon: +33 176217220
Fax: +33 176217221
E-mail: -

Company Profile

-

Board of directors

Michael WyzgaChairman of Supervisory Board
José-Alain SahelMember of Supervisory Board
Maritza McIntyreMember of Supervisory Board
Peter GoodfellowMember of Supervisory Board
Simone SeiterMember of Supervisory Board
Cédric MoreauMember of Supervisory Board
Elsy Boglioli HofmanMember of Supervisory Board
Françoise de CraeckerMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.